In this morning's issue of Stock--d's newsletter they give a coverage of Optiscan's current attributes: "Relief of pathologist shortage, Benefits in inttraoperative pathology, Improving diagnosis of oral cancer, Digital pathology will replace the glass slide etc. etc."
Much, if not all has been mentioned here recently, but it's nice to have coverage from an additional source.
Dory, can you upload and post here - sorry, I'm a Luddite in these technical matters.
MM
In this morning's issue of Stock--d's newsletter they give a...
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.00M | |||
| Open | High | Low | Value | Volume |
| 8.6¢ | 8.6¢ | 8.5¢ | $12.74K | 148.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 48792 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 91564 | 2 |
View Market Depth
| Last trade - 12.06pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.5¢ |
Change
0.000 ( 2.41 %) |
||||
| Open | High | Low | Volume | ||
| 8.5¢ | 8.5¢ | 8.5¢ | 7593 | ||
| Last updated 12.06pm 29/04/2024 ? | |||||
| OIL (ASX) Chart |